An Ad Hoc Random Initialization Deep Neural Network Architecture for Discriminating Malignant Breast Cancer Lesions in Mammographic Images

Breast cancer is one of the most common cancers in women, with more than 1,300,000 cases and 450,000 deaths each year worldwide. In this context, recent studies showed that early breast cancer detection, along with suitable treatment, could significantly reduce breast cancer death rates in the long term. X-ray mammography is still the instrument of choice in breast cancer screening. In this context, the false-positive and false-negative rates commonly achieved by radiologists are extremely arduous to estimate and control although some authors have estimated figures of up to 20% of total diagnoses or more. The introduction of novel artificial intelligence (AI) technologies applied to the diagnosis and, possibly, prognosis of breast cancer could revolutionize the current status of the management of the breast cancer patient by assisting the radiologist in clinical image interpretation. Lately, a breakthrough in the AI field has been brought about by the introduction of deep learning techniques in general and of convolutional neural networks in particular. Such techniques require no a priori feature space definition from the operator and are able to achieve classification performances which can even surpass human experts. In this paper, we design and validate an ad hoc CNN architecture specialized in breast lesion classification from imaging data only. We explore a total of 260 model architectures in a train-validation-test split in order to propose a model selection criterion which can pose the emphasis on reducing false negatives while still retaining acceptable accuracy. We achieve an area under the receiver operatic characteristics curve of 0.785 (accuracy 71.19%) on the test set, demonstrating how an ad hoc random initialization architecture can and should be fine tuned to a specific problem, especially in biomedical applications.

[1]  T. Helbich,et al.  Probably benign breast masses at US: is follow-up an acceptable alternative to biopsy? , 2007, Radiology.

[2]  Danna Zhou,et al.  d. , 1840, Microbial pathogenesis.

[3]  Olaf Sporns,et al.  Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology. , 2018, Journal of Alzheimer's disease : JAD.

[4]  Pascal Vincent,et al.  Representation Learning: A Review and New Perspectives , 2012, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[5]  Jürgen Schmidhuber,et al.  Deep learning in neural networks: An overview , 2014, Neural Networks.

[6]  Rob Fergus,et al.  Visualizing and Understanding Convolutional Networks , 2013, ECCV.

[7]  Daniel Lévy,et al.  Breast Mass Classification from Mammograms using Deep Convolutional Neural Networks , 2016, ArXiv.

[8]  William Hang,et al.  GlimpseNet : Attentional Methods for Full-Image Mammogram Diagnosis , 2017 .

[9]  W. Marsden I and J , 2012 .

[10]  Aaas News,et al.  Book Reviews , 1893, Buffalo Medical and Surgical Journal.

[11]  Benzhong Wang,et al.  Herceptin as a single agent in the treatment of patients with metastatic breast cancer. , 2015, Journal of cancer research and therapeutics.

[12]  Yuan Yu,et al.  TensorFlow: A system for large-scale machine learning , 2016, OSDI.

[13]  Richard H. Moore,et al.  Current Status of the Digital Database for Screening Mammography , 1998, Digital Mammography / IWDM.

[14]  Brendan J. Frey,et al.  Machine Learning in Genomic Medicine: A Review of Computational Problems and Data Sets , 2016, Proceedings of the IEEE.

[15]  John M S Bartlett,et al.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2014, Archives of pathology & laboratory medicine.

[16]  M. Wallis,et al.  A review of false negative mammography in a symptomatic population. , 1991, Clinical radiology.

[17]  Thomas Brox,et al.  U-Net: Convolutional Networks for Biomedical Image Segmentation , 2015, MICCAI.

[18]  Niall O'Higgins,et al.  Analysis of patients with false negative mammography and symptomatic breast carcinoma , 2007, Journal of surgical oncology.

[19]  Li Shen,et al.  End-to-end Training for Whole Image Breast Cancer Diagnosis using An All Convolutional Design , 2017, ArXiv.

[20]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[21]  Orazio Schillaci,et al.  Personalized medicine: a new option for nuclear medicine and molecular imaging in the third millennium , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  Guang Shi,et al.  Molecular markers' progress of breast cancer treatment efficacy. , 2015, Journal of cancer research and therapeutics.

[23]  C. D'Orsi,et al.  Diagnostic Performance of Digital Versus Film Mammography for Breast-Cancer Screening , 2005, The New England journal of medicine.

[24]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[25]  Orazio Schillaci,et al.  Management of oncological patients in the digital era: anatomic pathology and nuclear medicine teamwork. , 2018, Future oncology.

[26]  Thomas de Quincey [C] , 2000, The Works of Thomas De Quincey, Vol. 1: Writings, 1799–1820.

[27]  Alfonso Frigerio,et al.  False-Positive Results in Mammographic Screening for Breast Cancer in Europe: A Literature Review and Survey of Service Screening Programmes , 2012, Journal of medical screening.

[28]  R.L.N Godone,et al.  Clinical and molecular aspects of breast cancer: Targets and therapies. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[29]  J. Geraghty,et al.  Reasons underlying negative mammography in patients with palpable breast cancer. , 1994, Clinical radiology.

[30]  Miguel Ángel Guevara-López,et al.  Representation learning for mammography mass lesion classification with convolutional neural networks , 2016, Comput. Methods Programs Biomed..

[31]  Geoffrey E. Hinton,et al.  Deep Learning , 2015, Nature.

[32]  Phoebe E. Freer,et al.  False-negative rate of combined mammography and ultrasound for women with palpable breast masses , 2015, Breast Cancer Research and Treatment.

[33]  Ausif Mahmood,et al.  A Framework for Designing the Architectures of Deep Convolutional Neural Networks , 2017, Entropy.

[34]  Tsuyoshi Murata,et al.  {m , 1934, ACML.

[35]  Yann LeCun,et al.  Convolutional networks and applications in vision , 2010, Proceedings of 2010 IEEE International Symposium on Circuits and Systems.

[36]  E. Pisano,et al.  Consequences of false-positive screening mammograms. , 2014, JAMA internal medicine.

[37]  Hiba Chougrad,et al.  Deep Convolutional Neural Networks for breast cancer screening , 2018, Comput. Methods Programs Biomed..

[38]  Ping Tang,et al.  Update on Immunohistochemical Analysis in Breast Lesions. , 2017, Archives of pathology & laboratory medicine.

[39]  P. Alam ‘A’ , 2021, Composites Engineering: An A–Z Guide.

[40]  H. Nelson,et al.  Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.

[41]  Jay Parikh,et al.  Improved prognosis of women aged 75 and older with mammography-detected breast cancer. , 2014, Radiology.

[42]  P. Alam ‘E’ , 2021, Composites Engineering: An A–Z Guide.

[43]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[44]  P. Alam,et al.  R , 1823, The Herodotus Encyclopedia.